Skip to main content
Donate
Login
IASLC's 50th Anniversary
IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
About Us
About Us
2023 Annual Report
Strategic Plan
Board of Directors
Committees
Awards
Staff
Careers
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2023 Highlights
Research & Education
Research & Education
Publications, Resources & Guidelines
Publications, Resources & Guidelines
Guide to COVID-19 and Lung Cancer
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Lung Cancer 360
Research Projects
Research Projects
Staging Project
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Early-Career Opportunities
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
Partner Society Membership Offers
Patient Advocacy
Patient Advocacy
STARS
Advocacy Partner Spotlight
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 1 - 12 items out of 39 results
ILCN article
More Options Needed After First-Line Chemoimmunotherapy in Lung Cancer
ILCN article
IASLC Studying Impact of COVID-19 on International Lung Cancer Clinical Trial Enrollment, Mitigation Strategies
ILCN article
Cancer Clinical Trial Compensation: Undue or Long Overdue?
ILCN article
Revised U.S. Food and Drug Administration Trial Eligibility Guidance: A Major Step Toward Transforming Lung Cancer Clinical Trials
ILCN article
ADAURA: Data is Only Part of the Story
ILCN article
Additional ADAURA Analyses Help Support the Benefit of Adjuvant Osimertinib in Patients With Resected EGFR-Mutated NSCLC
ILCN article
Redefining Good Quality Resections in NSCLC
ILCN article
The IASLC Supports International Day for Clean Air for Blue Skies “Healthy Air, Healthy Planet” Campaign
ILCN article
Screening for the Biggest Cancer Killer: Beating Lung Cancer Through Screening Guidelines?
ILCN article
A Roadmap to Improving Lung Cancer Care in the Middle East and North Africa
ILCN article
Lung Cancer in the Brazilian Health System: Screening, Drug Approvals, Barriers to Care, and Success Stories
ILCN article
Ireland’s Complex Healthcare System and Its Relation to Innovative Ways for Patients to Access Trials
Pagination
1
2
3
4
›
Next page
Last
Last page